Prism Johnson (500338) Q2 25/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/25 earnings summary
21 Aug, 2026Executive summary
Q2 FY25 consolidated revenue declined to ₹1,538 crore (ex-RQBE) and ₹1,685.38 crore (reported), mainly due to a 17.3% YoY drop in cement revenue; HRJ and RMC revenues were largely flat YoY.
EBITDA fell 36.1% YoY to ₹57 crore, with margin down 170 bps YoY to 3.7% due to lower realizations and higher costs in cement and HRJ segments.
Net loss after tax for Q2 FY25 was ₹(91) crore to ₹89.79 crore, compared to a profit in the prior year, reflecting operational pressures and higher finance costs.
The company acquired 50% equity in Sunbath Sanitary Private Limited in August 2024, making it a subsidiary.
Financial highlights
Prism Cement revenue dropped 17.3% YoY to ₹623 crore; HRJ down 1.1% YoY to ₹575 crore; RMC down 0.4% YoY to ₹340 crore; Insurance segment revenue was ₹151.34 crore.
EBITDA per ton for cement plunged from ₹364 in Q2 FY24 to ₹58 in Q2 FY25, mainly due to lower realizations and maintenance shutdowns.
Free cash flow (pre-capex) was negative ₹181 crore, impacted by large LC payments.
Net debt increased to ₹1,188 crore; outstanding consolidated debt was ₹1,358.83 crore as of September 30, 2024.
EPS for Q2 FY25 was ₹(1.78), compared to ₹3.63 in Q2 FY24.
Outlook and guidance
Management targets to regain past peak performance in the medium term, focusing on cost competitiveness, premium product mix, and capacity utilization.
Cement demand outlook remains strong, but competition is expected to intensify with new capacity additions in Central India.
The results include the impact of the Sunbath Sanitary acquisition from August 22, 2024, making current period results not directly comparable to previous periods.
Latest events from Prism Johnson
- FY25 revenue reached ₹7,310 crore with strong cash flow and focus on sustainability and innovation.500338
Corporate presentation - Q1 FY25 revenue fell, EBITDA margin improved to 9.3%, but net loss reached ₹7.70 crore.500338
Q1 24/25 - Q3 FY25 revenue and net profit improved, but EBITDA and margins declined sharply.500338
Q3 24/25 - FY25 profit dropped on margin pressures and exceptional items, with debt reduction and asset sale.500338
Q4 24/25 - Revenue grew year-over-year, but profit declined amid margin pressures and arbitration.500338
Q1 25/26 - Quarterly profit returned with higher margins, led by cement and HRJ segment growth.500338
Q2 25/26 - Profitability and margins rose sharply, aided by asset sales despite labor code expenses.500338
Q3 25/26 - Revenue and EBITDA rose, but net profit was hit by exceptional items and insurance sale pending.500338
Q4 25/26 - Record EBITDA growth and profit surge driven by asset sales and insurance divestment.500338
Q1 26/27